We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.8B
AUM Growth
+$1.26B
Cap. Flow
+$567M
Cap. Flow %
3.2%
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$64.8M
2
HRL icon
Hormel Foods
HRL
+$61.4M
3
GILD icon
Gilead Sciences
GILD
+$59.9M
4
HLT icon
Hilton Worldwide
HLT
+$54.7M
5
FTI icon
TechnipFMC
FTI
+$51M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Healthcare 14.18%
3 Financials 11.71%
4 Industrials 10.79%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCY icon
1026
Mercury Insurance
MCY
$5.98B
$236K ﹤0.01%
4,325
+343
+9% +$18.5K
TILT icon
1027
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.17B
$235K ﹤0.01%
2,600
-100
-4% -$8.96K
TRI icon
1028
Thomson Reuters
TRI
$42.7B
$235K ﹤0.01%
4,924
+458
+10% +$22.2K
OAK
1029
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$233K ﹤0.01%
5,500
-1,500
-21% -$67.1K
NRT
1030
North European Oil Royalty Trust
NRT
$80.1M
$230K ﹤0.01%
30,000
PRK icon
1031
Park National Corp
PRK
$3.43B
$229K ﹤0.01%
2,395
PFF icon
1032
iShares Preferred and Income Securities ETF
PFF
$13.2B
$228K ﹤0.01%
5,790
+2,572
+80% +$103K
SRNE
1033
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$225K ﹤0.01%
29,135
RWX icon
1034
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
$224K ﹤0.01%
5,383
+375
+7% +$15.8K
CHL
1035
DELISTED
China Mobile Limited
CHL
$223K ﹤0.01%
3,645
+39
+1% +$2.39K
MOG.A icon
1036
Moog Inc Class A
MOG.A
$13.1B
$217K ﹤0.01%
3,648
CHKP icon
1037
Check Point Software Technologies
CHKP
$13.7B
$216K ﹤0.01%
2,800
-35
-1% -$2.71K
NEOG icon
1038
Neogen
NEOG
$2.07B
$216K ﹤0.01%
10,331
+54
+0.5% +$1.16K
TRCB
1039
DELISTED
Two River Bancorp
TRCB
$216K ﹤0.01%
19,713
CBT icon
1040
Cabot Corp
CBT
$4.55B
$215K ﹤0.01%
4,115
SWN
1041
DELISTED
Southwestern Energy Company
SWN
$215K ﹤0.01%
15,556
+3,561
+30% +$49.4K
CALM icon
1042
Cal-Maine
CALM
$4.2B
$214K ﹤0.01%
5,574
BIO icon
1043
Bio-Rad Laboratories Class A
BIO
$8.54B
$213K ﹤0.01%
1,306
CHH icon
1044
Choice Hotels
CHH
$5.17B
$210K ﹤0.01%
4,671
+1,231
+36% +$59.1K
TECH icon
1045
Bio-Techne
TECH
$11.2B
$209K ﹤0.01%
7,688
-212
-3% -$5.82K
UHT
1046
Universal Health Realty Income Trust
UHT
$615M
$209K ﹤0.01%
3,321
DISCK
1047
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$208K ﹤0.01%
7,985
+2,452
+44% +$60.8K
TFCFA
1048
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$208K ﹤0.01%
8,671
+554
+7% +$14.2K
HSEB.CL
1049
DELISTED
HSBC Holdings plc
HSEB.CL
$208K ﹤0.01%
8,000
BIP icon
1050
Brookfield Infrastructure Partners
BIP
$18.5B
$207K ﹤0.01%
10,080

Similar funds

Glenmede Trust's Q3 2016 Portfolio in Review

As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.

  • Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
  • Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
  • Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
  • Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
  • Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
  • Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
  • Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.